Stay updated on Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.

Latest updates to the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoChange DetectedThe page now shows Revision: v3.5.4, indicating a newer build of the study entry.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedThe page's revision history now shows Revision: v3.5.3, replacing the previous Revision: v3.5.2.SummaryDifference0.0%

- Check39 days agoChange DetectedRevision: v3.5.2 is now listed, replacing the previous v3.5.0 entry. This reflects a minor software version update.SummaryDifference0.0%

- Check68 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0; no study content or user-facing information was changed.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page revision was updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check103 days agoChange DetectedA new Revision: v3.4.2 is shown, and an outdated government funding operating-status notice has been removed.SummaryDifference0.4%

Stay in the know with updates to Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Viagenpumatucel-L Combo Therapy in NSCLC Clinical Trial page.